Have a feature idea you'd love to see implemented?
Let us know!
CRIS Curis Inc
Price (delayed)
$5.33
Market cap
$31.87M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$8.21
Enterprise value
$25.43M
Curis is a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer. In 2015, Curis entered into a collaboration with Aurigene in the areas of
Highlights
Curis's EPS has increased by 18% YoY and by 5% QoQ
The gross profit has grown by 4.3% from the previous quarter
The equity has plunged by 107% from the previous quarter and by 103% YoY
CRIS's quick ratio has dropped by 76% year-on-year and by 58% since the previous quarter
Key stats
What are the main financial stats of CRIS
Market
Valuations
Earnings
Shares outstanding
5.98M
Market cap
$31.87M
Enterprise value
$25.43M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
3.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.5
Revenue
$10.16M
EBIT
-$47.57M
EBITDA
-$45.95M
Free cash flow
-$42.73M
Per share
Balance sheet
Liquidity
EPS
-$8.21
Free cash flow per share
-$7.34
Book value per share
-$0.12
Revenue per share
$1.75
TBVPS
$7.12
Total assets
$50.41M
Total liabilities
$51.11M
Debt
$3.56M
Equity
-$694,000
Working capital
$15.16M
Debt to equity
-5.13
Current ratio
1.78
Quick ratio
1.6
Net debt/EBITDA
0.14
Margins
Efficiency
Dividend
EBITDA margin
-452.2%
Gross margin
98.3%
Net margin
-468.2%
Operating margin
-487.6%
Return on assets
-68%
Return on equity
-327.9%
Return on invested capital
-193.8%
Return on capital employed
-153.2%
Return on sales
-468.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CRIS stock price
How has the Curis stock price performed over time
Intraday
0.76%
1 week
0%
1 month
-9.81%
1 year
25.41%
YTD
-58.2%
QTD
-1.11%
Financial performance
How have Curis's revenue and profit performed over time
Revenue
$10.16M
Gross profit
$9.99M
Operating income
-$49.55M
Net income
-$47.57M
Gross margin
98.3%
Net margin
-468.2%
CRIS's operating margin is down by 7% year-on-year but it is up by 2.7% since the previous quarter
Curis's operating income has decreased by 6% YoY
The gross profit has grown by 4.3% from the previous quarter
CRIS's net margin is up by 3.7% from the previous quarter
Growth
What is Curis's growth rate over time
Valuation
What is Curis stock price valuation
P/E
N/A
P/B
N/A
P/S
3.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.5
Curis's EPS has increased by 18% YoY and by 5% QoQ
The equity has plunged by 107% from the previous quarter and by 103% YoY
CRIS's price to sales (P/S) is 86% lower than its 5-year quarterly average of 21.6 and 41% lower than its last 4 quarters average of 5.2
The revenue has increased by 3.6% since the previous quarter
Efficiency
How efficient is Curis business performance
CRIS's return on equity has dropped by 181% year-on-year and by 46% since the previous quarter
The ROIC has plunged by 149% YoY and by 34% from the previous quarter
The company's return on assets fell by 45% YoY and by 12% QoQ
Curis's return on sales has increased by 3.7% QoQ
Dividends
What is CRIS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CRIS.
Financial health
How did Curis financials performed over time
CRIS's quick ratio has dropped by 76% year-on-year and by 58% since the previous quarter
The current ratio has dropped by 75% year-on-year and by 56% since the previous quarter
The equity has plunged by 107% from the previous quarter and by 103% YoY
CRIS's debt is up by 43% from the previous quarter and by 5% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.